Effect of Atenolol on Mortality and Cardiovascular Morbidity after Noncardiac Surgery

Abstract

In patients who have or are at risk for coronary artery disease who must undergo noncardiac surgery, treatment with atenolol during hospitalization can reduce mortality and the incidence of cardiovascular complications for as long as two years after surgery.